Clinical Trial Update: Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia [NA]

View source ↗

Summary

A completed clinical trial evaluating a combination of dextromethorphan, gabapentin, and oxycodone for opioid-induced hyperalgesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid-induced Hyperalgesia

Drugs mentioned

• Dextromethorphan (dextromethorphan)
• Gabapentin (Gabapentin)
• Oxycodone (oxycodone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Hyperalgesia, Opioid-Related Disorders | NA | Status: COMPLETED